Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$88.00
-4.32%
Mkt Cap $7.90B
Analyst Ratings
Buy
24
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
Implied Upside
+11.0%
Consensus $97.64 vs current $88.00
NASDAQ·Healthcare·Biotechnology
$88.00
-4.32%
Mkt Cap $7.90B
Buy
24
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
+11.0%
Consensus $97.64 vs current $88.00